|
|
 Previous Article | Table of Contents | Next Article 
Spread of Human Cytomegalovirus (HCMV) After Infection of Human Hematopoietic Progenitor Cells: Model of HCMV Latency
T. Zhuravskaya,
J.P. Maciejewski,
D.M. Netski,
E. Bruening,
F.R. Mackintosh, and
S. St Jeor
From the Department of Microbiology, Cell and Molecular Biology Program School of Medicine, and the Department of Internal Medicine, School of Medicine, University of Nevada, Reno, NV.
Clinical experience and laboratory data suggest that human cytomegalovirus (HCMV) is present in peripheral blood of seropositive individuals in a latent or persistent state and can be transmitted via blood products and be reactivated in seropositive imunocompromised patients. The pathophysiology of HCMV latency and the nature of HCMV interaction with hematopoietic cells remains unknown. In this study, we investigated the infection of bone marrow (BM) progenitor cells and their progeny as a model of HCMV latency. A clinical isolate and the recombinant laboratory strain Towne/lox containing the Escherichia coli  galactosidase (-gal) gene regulated by immediately early (IE) HCMV promoter were used to infect highly purified CD34+ cells. Although the infection of these cells with a clinical isolate was associated with an inhibition of proliferation by 59%, an expansion of progeny derived from these cells was possible. Polymerase chain reaction analysis and staining for -gal have shown that HCMV persisted in infected BM CD34+ cells and their progeny for up to 4 weeks. However, IE and late gene products (mRNA and protein) were detected only late in the course of infection and their expression correlated with terminal macrophage differentiation of the CD34+-derived progeny. Although early infection of CD34+ progenitor cells was not productive (as shown by the plaque assay), infectious virus could be recovered from the terminally differentiated cultures. BM progenitor cells may serve as a reservoir of the latent virus with limited transcription. Proliferation and monocytic maturation of infected progenitors may lead to the numerical expansion of HCMV-infected cells, which serve as a source of HCMV dissemination and reactivation.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2482-2491
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Goodrum, M. Reeves, J. Sinclair, K. High, and T. Shenk
Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro
Blood,
August 1, 2007;
110(3):
937 - 945.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Keller, A. W. Wu, J. I. Andrews, P. W. McGonagill, E. E. Tibesar, and J. L. Meier
Reversal of Human Cytomegalovirus Major Immediate-Early Enhancer/Promoter Silencing in Quiescently Infected Cells via the Cyclic AMP Signaling Pathway
J. Virol.,
June 15, 2007;
81(12):
6669 - 6681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Wu, J. Vieira, N. Fiore, P. Banerjee, M. Sieburg, R. Rochford, W. Harrington Jr, and G. Feuer
KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo
Blood,
July 1, 2006;
108(1):
141 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bego, J. Maciejewski, S. Khaiboullina, G. Pari, and S. St. Jeor
Characterization of an Antisense Transcript Spanning the UL81-82 Locus of Human Cytomegalovirus
J. Virol.,
September 1, 2005;
79(17):
11022 - 11034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Goodrum, C. T. Jordan, S. S. Terhune, K. High, and T. Shenk
Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations
Blood,
August 1, 2004;
104(3):
687 - 695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Kosugi, H. Kawasaki, Y. Arai, and Y. Tsutsui
Innate Immune Responses to Cytomegalovirus Infection in the Developing Mouse Brain and Their Evasion by Virus-Infected Neurons
Am. J. Pathol.,
September 1, 2002;
161(3):
919 - 928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rehm, A. Engelsberg, D. Tortorella, I. J. Korner, I. Lehmann, H. L. Ploegh, and U. E. Hopken
Human Cytomegalovirus Gene Products US2 and US11 Differ in Their Ability To Attack Major Histocompatibility Class I Heavy Chains in Dendritic Cells
J. Virol.,
April 16, 2002;
76(10):
5043 - 5050.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Crapnell, E. D. Zanjani, A. Chaudhuri, J. L. Ascensao, S. St. Jeor, and J. P. Maciejewski
In vitro infection of megakaryocytes and their precursors by human cytomegalovirus
Blood,
January 15, 2000;
95(2):
487 - 493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Lockridge, G. Sequar, S. S. Zhou, Y. Yue, C. P. Mandell, and P. A. Barry
Pathogenesis of Experimental Rhesus Cytomegalovirus Infection
J. Virol.,
November 1, 1999;
73(11):
9576 - 9583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Hanson, J. S. Slater, Z. Karabekian, H. W. Virgin IV, C. A. Biron, M. C. Ruzek, N. van Rooijen, R. P. Ciavarra, R. M. Stenberg, and A. E. Campbell
Replication of Murine Cytomegalovirus in Differentiated Macrophages as a Determinant of Viral Pathogenesis
J. Virol.,
July 1, 1999;
73(7):
5970 - 5980.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Luppi, P. Barozzi, C. Morris, A. Maiorana, R. Garber, G. Bonacorsi, A. Donelli, R. Marasca, A. Tabilio, and G. Torelli
Human Herpesvirus 6 Latently Infects Early Bone Marrow Progenitors In Vivo
J. Virol.,
January 1, 1999;
73(1):
754 - 759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
